Technologies, Inc. is a biopharmaceutical company focused on the
discovery and development of pharmaceutical products to improve
human health. We have built drug discovery capabilities that can
support various research and development projects. Genelabs is
currently concentrating these capabilities on discovering novel
compounds that selectively inhibit replication of the hepatitis
C virus and advancing preclinical development of compounds from
this hepatitis C virus drug discovery program, while also
developing a late-stage product for lupus. We believe that these
high-risk, potentially high reward programs focus our research
and development expertise in areas where we have the opportunity
to generate either first-in-class or best-in-class products that
will address diseases for which current therapies are
Requests for Investor Information
To receive investor information, you may complete and submit this form or send an e-mail to firstname.lastname@example.org. You may also contact us by telephone or mail.
Cheap propecia online and other generics can be bought here.